Drug Discovery World

MARCH 6, 2023

CHI is a rare genetic disease in which cells secrete excess insulin, causing hypoglycemia, which can result in serious health outcomes including seizures, coma, permanent brain damage and death. Xinvento is developing novel investigational therapeutic candidates designed to improve the care of patients with CHI.

Disease 130

Disease Pharmaceuticals Therapies Treatment 130

Drugs.com

JANUARY 24, 2024

24, 2024 -- Heart disease remains the United States’ top cause of death, but progress is being made and more lives are being saved, a new report finds.There were 931,578 heart-related deaths in 2021, an increase of less than 3,000. WEDNESDAY, Jan.

Disease 105

Disease 105

Drug Discovery World

DECEMBER 22, 2022

Shelley McLendon , SVP of Vaccine and Infectious Diseases Program Management at ICON, attended the World Vaccine Congress Europe from 16-19 October 2022 in Barcelona, Spain. Disease surveillance and reporting . Disease surveillance is the collection and monitoring of data on disease within a population.

Vaccine 130

Vaccine Disease Clinical Trials Trials 130

Drug Discovery World

FEBRUARY 10, 2023

Breast cancer retained its position as the most-studied disease area in clinical trials in 2022, despite a drop in activity, according to analysis from analytics company Phesi. However, the reduction in breast cancer trials is unexpected, with 113 fewer recruiting trials in 2022 compared with 2021. Download the full report.

Disease 130

Disease Clinical Trials Clinical Development Trials 130

Drug Discovery World

MARCH 2, 2023

A rare disease is defined as a condition which affects less than one in 2000 people. million) in the UK being affected by a rare disease at some point in their lives. This has left many living with rare diseases without available or approved treatments and support for their conditions. This needs to change.

Drug Development 130

Drug Development Disease Clinical Trials Drugs 130

The Pharma Data

MARCH 9, 2021

New data from 10 studies will be presented by Eli Lilly and Company (NYSE: LLY) at the upcoming virtual International Conference on Alzheimer’s & Parkinson Diseases 2021 (AD/PD 2021), March 9-14, 2021. vice president of Alzheimer’s disease development unit, Eli Lilly and Company.

Disease 40

Disease International Research Therapies 40

Drug Target Review

JULY 7, 2023

Approximately three percent of the global population — 240 million people — experience autoantibody diseases, which occur when one’s own body attacks critical organs and tissues. This can create an abnormal immune response that attacks the cells of our bodies and contributes to the development of autoantibody diseases.

Disease 98

Disease Immune Response Therapies Treatment 98

Drug Target Review

JUNE 3, 2024

How does COUR Pharmaceuticals’ immune-modifying nanoparticle platform differ from traditional approaches to treating immune-mediated diseases? Essentially, our CNPs reprogramme the immune system by restoring balance and returning the body to a homeostatic state, offering a precise approach to treating immune-mediated diseases.

Disease 49

Disease Pharmaceuticals Therapies Clinical Trials 49

The Pharma Data

JULY 23, 2021

(Nasdaq: BIIB) today announced it will share multiple oral and poster presentations from its Alzheimer’s disease clinical development portfolio at the Alzheimer’s Association International Conference (AAIC), which will be held in Denver, Colorado and online July 26-30, 2021.

International 52

International Disease Clinical Trials Trials 52

Drug Discovery World

FEBRUARY 20, 2023

Breast cancer retained its position as the most-studied disease area in clinical trials in 2022, according to a recent report by analytics company Phesi. Here, we take a look at the top four disease areas and some of the key developments in 2022. The post What are the top disease areas for clinical drug trials?

Trials 130

Trials Drug Trials Disease Clinical Trials 130

Eye on FDA

JANUARY 5, 2022

But before heading into 2022, it is perhaps time to take stock of AdComms and what they did or did not do during 2021. First and foremost is that as noted earlier this year (See August 5, 2021 FDA Adcomms – Is FDA Getting Less Advice? ), there were fewer 2021 meetings held to consider new drug applications than in years gone by.

FDA 76

FDA Clinical Pharmacology Vaccine Production 76

The Pharma Data

JULY 8, 2021

Nasdaq:BIIB) today announced it will report second quarter 2021 financial results Thursday, July 22, 2021, before the financial markets open. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies.

Biosimilars 52

Biosimilars Disease Therapies Treatment 52

The Pharma Data

APRIL 9, 2021

today announced it will report first quarter 2021 financial results Thursday, April 22, 2021, before the financial markets open. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies.

Biosimilars 52

Biosimilars Disease Therapies Treatment 52

Drugs.com

JUNE 19, 2023

In 2021, an estimated 9.6 MONDAY, June 19, 2023 -- Nearly 10 million Americans are at risk for blindness from diabetic retinopathy, a new study finds. million people in the United States — 26% of those with diabetes — had the eye illness and.

Disease 105

Disease 105

The Pharma Data

MARCH 5, 2021

Biogen (Nasdaq: BIIB) today announced it will host webcasts of its pre-recorded presentations and live discussions related to its Alzheimer’s disease investigational therapy, aducanumab, at the upcoming AD/PDTM 2021 Virtual Conference. AD/PD Webcast Schedule Details: Wednesday, March 10, 2021, 6:45 a.m.

Licensing 52

Licensing Licensing Biosimilars Disease 52

The Pharma Data

AUGUST 1, 2021

per share dividend for the third quarter of 2021. The dividend will be paid on September 8, 2021, to all stockholders of record as of the close of business on August 17, 2021. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Disease 52

Disease 52

The Pharma Data

JUNE 30, 2021

he board of directors of Eli Lilly and Company (NYSE: LLY) (the “Board”) has declared a dividend for the third quarter of 2021 of $0.85 The dividend is payable on September 10, 2021 to shareholders of record at the close of business on August 13, 2021. per share on outstanding common stock. www.lilly.com ?and?

Disease 52

Disease 52

Drug Discovery World

DECEMBER 6, 2023

Gremlin 1 cells present opportunities for cartilage regeneration and their discovery will have relevance to other forms of cartilage injury and disease, which are notoriously challenging to repair and treat. Though this discovery is currently limited to animal models, human trials are underway.

Medical Schools 264

Medical Schools Clinical Trials Pharmaceuticals Trials 264

The Pharma Data

JUNE 30, 2021

For their remarkable scientific contributions, doctoral student Julia Klaus, Zurich University VetSuisse Faculty, and Dr Yasmin Parr from the MRC-University of Glasgow, Centre for Virus Research, have received the 2021 ABCD Young Scientist Award. References. For more information, please visit www.abcdcatsvets.org.

Immune Response 52

Immune Response Virus Disease Doctors 52

Drug Target Review

JUNE 21, 2023

Most rare diseases are caused by a single gene defect, but severity can vary considerably among patients. Modifier genes can help explain that variability and can alter or even prevent disease onset and progression, making them appealing therapeutic targets. However, the identification of these genes is challenging.

Disease 110

Disease Clinical Trials Therapies Science 110

The Pharma Data

MARCH 4, 2021

per share dividend for the second quarter of 2021. The dividend will be paid on June 8, 2021, to all stockholders of record as of the close of business on May 17, 2021. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Disease 52

Disease 52

The Pharma Data

AUGUST 3, 2021

Revenue in the second quarter of 2021 increased 23 percent, driven by volume growth of 22 percent. – Revenue from all key products grew in the quarter and 2021 year-to-date. . – Revenue from all key products grew in the quarter and 2021 year-to-date. – 2021 EPS guidance updated to be in the range of $6.73

Production 52

Production Marketing Research Government 52

The Pharma Data

JANUARY 4, 2021

5, 2021 07:00 UTC. February 12, 2021. March 25, 2021. 2021 First Quarter Financial Update. April 21, 2021. 2021 Second Quarter Financial Update. July 21, 2021.

Clinical Trials 52

Clinical Trials Trials Treatment Disease 52

The Pharma Data

JANUARY 27, 2021

Centers for Disease Control and Prevention, the AP reported. © 2021 HealthDay. Posted: January 2021. Consumer News. Health Highlights: Jan. Government to Increase Vaccine Deliveries to States. In response to COVID-19 vaccine shortages, the U.S. ” His administration plans to make about 10.1 million, according to the U.S.

Vaccine 52

Vaccine Government Disease 52

The Pharma Data

JANUARY 1, 2021

1, 2021 – If you’re like most American adults, you’re not getting enough sleep. “Insufficient sleep contributes to the risk for several of today’s public health epidemics, including cardiovascular disease, diabetes and obesity,” he said in an academy news release. © 2021 HealthDay. FRIDAY, Jan.

Disease 52

Disease 52

The Pharma Data

JANUARY 10, 2021

Maybe we need to treat the host rather than the cell or the disease. I actually think neuroscience is going to heat up in 2021,” said Ben Zeskind , co-founder and CEO of Immuneering , which is using bioinformatics and computational biology to develop new drugs in this space, along with oncology and immuno-oncology.

Vaccine 52

Vaccine Regulations Small Molecule Disease 52

The Pharma Data

JULY 29, 2021

econd Quarter 2021 Product Sales Increased 21% Year-Over-Year Primarily Driven by Veklury. Nasdaq: GILD) announced today its results of operations for the second quarter 2021. “We Second Quarter 2021 Financial Results. Total second quarter 2021 revenue of $6.2 As of June 30, 2021, Gilead had $7.4

Science 52

Science Production Treatment FDA 52

BioPharma Drive: Drug Pricing

FEBRUARY 12, 2024

European venture firm Medicxi built the startup by combining six of its portolio companies, similar to when it merged 10 startups to form Centessa Pharmaceuticals in 2021.

Disease 59

Disease Pharmaceuticals Drugs 59

The Pharma Data

JANUARY 26, 2021

William Schaffner, an infectious diseases specialist at Vanderbilt University. Centers for Disease Control and Prevention. © 2021 HealthDay. Posted: January 2021. The Brazilian variant was first diagnosed in four travelers who were tested at an airport outside Tokyo. All rights reserved. Source link.

Doctors 52

Doctors Virus Disease Research 52

The Pharma Data

FEBRUARY 8, 2021

PARIS – February 5, 2021 – Today, Sanofi holds a virtual investor event with key members of the Sanofi leadership team to share and discuss the overall progress in implementing the strategy in core parts of the business as well as the transformation of R&D. Key highlights to be presented at Capital Markets Day 2021.

Marketing 52

Marketing Clinical Trials Disease Vaccine 52

The Pharma Data

JULY 29, 2021

Second-Quarter 2021 Revenues of $19.0 Billion The 10% Operational Growth Excluding BNT162b2(1) in Second-Quarter 2021 Builds on the 6% Operational Growth Delivered by the Comparable Business in Second-Quarter 2020 Second-Quarter 2021 Reported Diluted EPS(2) of $0.98, Adjusted Diluted EPS(3) of $1.07

Biosimilars 52

Biosimilars Vaccine International Production 52

The Pharma Data

AUGUST 1, 2021

to $6.14; Raises 2021 Adjusted Diluted EPS Guidance Range from $12.37 Based upon the momentum of our business, we are raising our full year 2021 EPS guidance and believe AbbVie is very well positioned for the long term.” ” Second-Quarter Results. Worldwide net revenues were $13.959 billion, an increase of 33.9

FDA 52

FDA Treatment Biosimilars International 52

The Pharma Data

JANUARY 4, 2021

Centers for Disease Control and Prevention has said that Covid-19 vaccines “are not interchangeable,” and that “the safety and efficacy of a mixed-product series have not been evaluated. © 2021 HealthDay. Posted: January 2021. The new guidance contradicts those in the United States, where the U.S.

Vaccine 52

Vaccine Virus Hospitals Production 52

Olympian Clinical Research

SEPTEMBER 16, 2022

million Americans were living with Alzheimer’s disease in 2021, according to the Centers for Disease Control and Prevention (CDC). Alzheimer’s disease is the seventh leading cause of death in the United States and is a devastating disease that can rob people of their memories and lives.

Disease 52

Disease Clinical Trials Clinical Research Trials 52

The Pharma Data

JANUARY 25, 2021

Centers for Disease Control and Prevention. © 2021 HealthDay. Posted: January 2021. All 10 severe allergic reaction (anaphylaxis) cases involving the Moderna vaccine occurred in women. Symptoms began a median of 7.5 minutes after vaccination. All patients that could be followed up with have recovered, according to the U.S.

Vaccine 52

Vaccine Pharmacy Government Disease 52

The Pharma Data

JANUARY 21, 2021

New research into exactly which genetic mutations increase breast cancer risk in women without a family history of the disease may help guide decisions about screening and preventive surgery, doctors say. © 2021 HealthDay. Posted: January 2021. Studies Pinpoint Genes That Raise Risk for Breast Cancer. All rights reserved.

Vaccine 52

Vaccine Doctors Government Research 52

The Pharma Data

APRIL 24, 2021

The COVID-19 pandemic highlights the importance of robust health systems to respond to disease outbreaks and to control other deadly diseases such as malaria. In 2020, we discovered another novel malaria therapy, INE963, which has an entirely new mechanism of action and is expected to begin clinical trials in 2021.

Clinical Trials 52

Clinical Trials Treatment Trials Disease 52